Literature DB >> 17918686

EBM metadata based on Dublin Core better presenting validity of clinical trials.

Wei Xu1, Mihoko Okada.   

Abstract

To help clinicians find better evidence, a metadata schema for Evidence Based Medicine (EBM) is developed. Dublin Core metadata standard (DC) was adopted to help build a metadata schema. An experimental system was developed to test the validity of the metadata and full text papers of clinical therapy on stomach ulcer extracted using PubMed. An EBM metadata schema was developed. Citations were created from original papers using the metadata schema. Three clinicians evaluated papers by utilizing metadata and full texts respectively. Agreement of evaluation was analyzed, and the result on weighted kappa was 0.55 (95% CI, 0.42-0.67). It reveals that there is moderate agreement between evaluation of metadata citations and full texts. It is possible to use the metadata to select papers before reading the full texts. A further study should be made to prove the applicability of the metadata in the real world setting.

Entities:  

Mesh:

Year:  2007        PMID: 17918686     DOI: 10.1007/s10916-007-9073-0

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  11 in total

Review 1.  The revised CONSORT statement for reporting randomized trials: explanation and elaboration.

Authors:  D G Altman; K F Schulz; D Moher; M Egger; F Davidoff; D Elbourne; P C Gøtzsche; T Lang
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

2.  Value of flow diagrams in reports of randomized controlled trials.

Authors:  M Egger; P Jüni; C Bartlett
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

Review 3.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

4.  Accuracy of data in abstracts of published research articles.

Authors:  R M Pitkin; M A Branagan; L F Burmeister
Journal:  JAMA       Date:  1999 Mar 24-31       Impact factor: 56.272

5.  Determining the sample size in a clinical trial.

Authors:  Adrienne Kirby; Val Gebski; Anthony C Keech
Journal:  Med J Aust       Date:  2002-09-02       Impact factor: 7.738

6.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

7.  The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials.

Authors:  Lise L Gluud; Thorkild I A Sørensen; Peter C Gøtzsche; Christian Gluud
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

8.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1994-01-05       Impact factor: 56.272

9.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

Review 10.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; Jeroen G Lijmer; David Moher; Drummond Rennie; Henrica C W de Vet
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

View more
  1 in total

1.  Construction of a Meta-Evidence Prototype Database of Traditional Chinese Medicine Splenogastric Diseases and Its Application in an Automatic Meta-Analysis System.

Authors:  Xueqin Zhang; Chunying Wang; Yanning Yao; Wenyu Sun; Yujie Guo; Lin Ma; Xinyuan Lu; Hongyong Deng
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-13       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.